Fred Alger Management »

Cytokinetics shares owned by Fred Alger Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Fred Alger Management from 13F filings

Historical chart of Fred Alger Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Fred Alger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Fred Alger Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0M 55k 54.96
2023-12-31 $1.7M 21k 83.49

More positions owned by Fred Alger Management

NVIDIA Corporation Equity (NVDA)
Microsoft Corporation Equity (MSFT)
Meta Platforms Inc Class A Equity (META)
Amazon.com Equity (AMZN)
AppLovin Corp. Class A Equity (APP)
Nebius Group N.V. Class A Equity (NBIS)
Apple Equity (AAPL)
Broadcom Equity (AVGO)
Alphabet Inc. Class C Equity (GOOG)
Talen Energy Corp Equity (TLN)
Tesla Equity (TSLA)
Sea Limited Sponsored ADR Class A Equity (SE)
Netflix Equity (NFLX)
Western Digital Corporation Equity (WDC)
Natera Equity (NTRA)

View all positions for Fred Alger Management

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Polar Capital Holdings
Rtw Investments
Susquehanna International
Integral Health Asset Management
Armistice Capital
UBS Group
Citadel Advisors

View all funds holding Cytokinetics